The failed proposal would fund Idaho public health services for fiscal year 2027, reduce authorized staff positions, and require reports on prevention programs and vaccines.
The department would receive $35,723,800 for public health services in fiscal year 2027, with funds assigned to physical health, laboratory services, and suicide prevention.
The department's laboratory services funding would be reduced by $78,400, and the Public Health Services Division would have three fewer authorized full-time positions.
The department would report on results and value for money in suicide and hepatitis prevention; it and Public Health Districts would report on HIV prevention.
The department would report how often these purchased vaccines are used and analyze savings for Idaho and service providers.
The Department of Health and Welfare would receive specified funding for its Public Health Services Division. The appropriation covers the department's Public Health Services Division. The money is assigned to physical health, laboratory services, and suicide prevention and awareness. The funding period runs from July 1, 2026, through June 30, 2027.
The department's laboratory services appropriation would be reduced by $78,400, and its authorized full-time positions would be reduced by three. The funding reduction applies to laboratory services and federal funds; the position reduction applies to the Public Health Services Division. Both reductions apply from July 1, 2026, through June 30, 2027.
The department would report on results and return on investment for suicide, HIV, and hepatitis prevention programs. The reports cover money appropriated for the three named prevention programs. The department and Public Health Districts would report together on HIV prevention; the department would report on the other two programs. The reports are due to the Joint Finance-Appropriations Committee by December 31, 2026.
The department would report on vaccine use and savings tied to purchases made through the Immunization Assessment Fund. The report concerns vaccines purchased using the Immunization Assessment Fund. The report would analyze savings for Idaho and service providers. The report is due to the Joint Finance-Appropriations Committee by December 31, 2026.
No hearings or votes scheduled.